Feedback at 5:00: Human Gene Argument

The Supreme Court is taking on a
case that could seriously impact medical research. 

The argument debates if a human gene
can be patented.

Biotech company “Myriad Genetics”
argues that its patent on human genes, called BRCA, is valid.

This pattern can
show if a person has a higher risk of ovarian or breast
cancer.

Opponents argue that no one was the
right to patent a part of the human body, because genes are a part of nature.
Myriad says it is simply putting a patent on a
sequence.

The Supreme Court's decision could
impact patents for vaccines, antibiotics, hormones and stem
cells.

What do you think of the case? It's
tonight's “Feedback at 5:00.”